Overview

  • Product name
    GSK-J4
  • Description
    Cell permeable histone demethylase JMJD3/UTX inhibitor
  • Alternative names
    • Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate
  • Biological description

    Cell permeable histone demethylase JMJD3/UTX inhibitor. Attenuates LPS-induced proinflammatory cytokine production in macrophages (IC50 = 9 μM, TNF-α release). Prodrug of GSK-J1. Rapidly hydrolyzes to GSK-J1 intracellularly.

  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Kruidenier L  et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488:404-8 (2012). Read more (PubMed: 22842901) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab144395.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up